Revolution Medicines

Revolution Medicines

Revolution Medicines

Raised
$70M
Follow us
Alexa global traffic share
Latest funding
$25,000,000
Venture capital (Series A) - 2016
Third Rock Ventures The Column Group
$45,000,000
Venture capital (Series A) - 2015
Third Rock Ventures
Team Size
1–10
Employees
Xconomy

Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer

Xconomy

Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers

MedCity News

Revolution Medicines secures $100M equity round, aiming for hard-to-reach oncology targets

Acquisition
PE HUB

Revolution Medicines is buying VC-backed Warp Drive Bio

Xconomy

Raising $56M, Revolution Medicines Drops Old Work and Turns to Cancer

Health Science Funding